Package Leaflet: Information for the Patient
Dutasteride/Tamsulosin Teva 0.5 mg/0.4 mg hard capsules
Dutasteride/Tamsulosin Hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Dutasteride/Tamsulosin Teva is used in men to treat an enlarged prostate (benign prostatic hyperplasia)- a non-cancerous growth of the prostate caused by overproduction of a hormone called dihydrotestosterone, in patients already controlled with dutasteride and tamsulosin administered at the same time.
Dutasteride/Tamsulosin Teva is a combination of two different medicines called dutasteride and tamsulosin. Dutasteride belongs to a group of medicines called 5-alpha reductase enzyme inhibitorsand tamsulosin belongs to a group of medicines called alpha blockers.
As the prostate grows, it can cause urinary problems such as difficulty in the flow of urine and a need to urinate more frequently. It can also cause the stream of urine to be weaker and less forceful. If benign prostatic hyperplasia is not treated, there is a risk that the flow of urine will be completely blocked (acute urinary retention). This requires immediate medical treatment. In some cases, surgery may be necessary to reduce the size of the prostate or to remove it.
Dutasteride reduces the production of dihydrotestosterone, which helps to reduce the size of the prostate and relieve symptoms. This reduces the risk of acute urinary retention and the need for surgery. Tamsulosin works by relaxing the muscles in the prostate, making it easier to urinate and quickly improving symptoms.
Do not take Dutasteride/Tamsulosin Teva:
Consult your doctorif you think you may be in any of these situations.
This medicine is for men only. It must not be taken by women, children, or adolescents.
Warnings and precautions
Consult your doctor before starting treatment with this medicine.
Using Dutasteride/Tamsulosin Teva with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. This includes any medicines bought without a prescription.
Do not take dutasteride/tamsulosin with these medicines:
It is not recommended to take dutasteride/tamsulosin with these medicines:
Certain medicines may interact with dutasteride/tamsulosin, which may increase the risk of you experiencing side effects. Some of these medicines are:
Tell your doctorif you are taking any of these medicines.
Taking Dutasteride/Tamsulosin Teva with food and drinks
You must take this medicine 30 minutes after the same meal each day.
Pregnancy, breast-feeding, and fertility
The use of Dutasteride/Tamsulosin Teva is contraindicated in women.
Pregnant women (or women who may be pregnant) must avoid contact with the contents of the capsules. Dutasteride is absorbed through the skin and may affect the normal development of a male baby. This risk is especially important during the first 16 weeks of pregnancy.
Use a condom during sexual intercourse. Dutasteride has been found in the semen of men taking dutasteride/tamsulosin. If your partner is pregnant or thinks she may be pregnant, she must avoid exposure to your semen.
Dutasteride/tamsulosin has been shown to decrease sperm count, motility, and semen volume. This may reduce male fertility.
Consult your doctorif a pregnant woman has come into contact with dutasteride/tamsulosin.
Driving and using machines
Some people may experience dizziness during treatment with this medicine, which may affect their ability to drive or operate machinery safely.
Do not drive or operate machineryif you are affected in this way.
Dutasteride/Tamsulosin Teva contains soybean lecithin and propylene glycol.
This medicine contains soybean lecithin, which may contain soybean oil. It must not be used in case of peanut or soy allergy.
This medicine contains 299 mg of propylene glycol per capsule.
Dutasteride/Tamsulosin Teva contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per capsule; this is essentially "sodium-free".
Follow the instructions for administration of this medicine exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.
If you do not take Dutasteride/Tamsulosin Teva regularly, your PSA levels may be affected.
What dose should you take
The recommended dose is one capsule once a day, 30 minutes after the same meal each day.
How to take it
The capsules should be swallowed whole, with water. Do not chew or open the capsules. Contact with the contents of the capsules can irritate your mouth or throat.
If you take more Dutasteride/Tamsulosin Teva than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Dutasteride/Tamsulosin Teva
Do not take a double dose to make up for forgotten doses. Take the next dose at the usual time.
Do not stop treatment with Dutasteride/Tamsulosin Teva
Do not stop treatment with this medicine without consulting your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Allergic reaction
Symptoms of an allergic reaction can include:
Contact your doctor immediatelyif you experience any of these symptoms and stop taking this medicine.
Dizziness, dizziness, and fainting
This medicine can cause dizziness, dizziness, and, in rare cases, fainting. You should be careful when getting up quickly after sitting or lying down, especially if you have to get up during the night, until you know how this medicine affects you. If you feel dizzy or experience dizziness during treatment, sit or lie down until these symptoms have disappeared.
Severe skin reactions
Signs of severe skin reactions can include:
Contact your doctor immediatelyif you have these symptoms and stop using this medicine.
Common side effects (may affect more than 1 in 10 people)
*In a small number of people, some of these adverse events may continue after stopping treatment with this medicine.
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Other side effects
Frequency cannot be estimated from the available data:
testicular pain and swelling
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible that they are not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
Store Dutasteride/Tamsulosin Teva below 25°C.
The product must be used within 90 days of opening.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Dutasteride/Tamsulosin Teva
The active ingredients are dutasteride and tamsulosin hydrochloride. Each capsule contains 0.5 mg of dutasteride and 0.4 mg of tamsulosin hydrochloride.
The other ingredients are:
Hard capsule shell:
Black iron oxide (E172)
Red iron oxide (E172)
Titanium dioxide (E171)
Yellow iron oxide (E172)
Gelatin
Soft capsule of dutasteride:
Contents of the soft capsule:
Glycerol monocaprylate
Butylhydroxytoluene (E321)
Soft capsule shell:
Gelatin
Glycerol
Titanium dioxide (E171)
Tamsulosin pellets:
Methacrylic acid - ethyl acrylate copolymer (1:1) dispersion 30 percent (also contains polysorbate 80 and sodium lauryl sulfate)
Microcrystalline cellulose
Dibutyl sebacate
Polysorbate 80
Hydrated colloidal silica
Calcium stearate
Black ink:
Shellac
Black iron oxide (E172)
Propylene glycol
Concentrated ammonia solution
Potassium hydroxide
Appearance of the Product and Container Contents
This medicinal product is presented in hard, oblong capsules, size 0EL, with a brown body and a beige cap, printed with C001 in black ink.
It is available in packs of 7, 30, and 90 capsules.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Teva B.V.
Swensweg 5, Haarlem
2031 GA
Netherlands
You can request more information about this medicinal product by contacting the local representative of the Marketing Authorization Holder:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11
Edificio Albatros B, 1ª planta
28108 Alcobendas, Madrid (Spain)
Manufacturer:
Laboratorios LEÓN FARMA, SA
C/La Vallina, s/n - Polígono Industrial Navatejera
24193 Villaquilambre (León)
Spain
G.L.Pharma GmbH
Schlossplatz 1
8502 Lannach
Austria
Adamed Pharma S.A.
ul. Marszalka Józefa Pilsudskiego 5
95-200 Pabianice
Poland
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Spain Dutasteride/Tamsulosin Teva 0.5 mg/0.4 mg hard capsules
Poland Adatam Duo
Estonia Dutamsin
Latvia Dutamsin 0.5 mg/0.4 mg hard capsules
Bulgaria Aglandin comp
Austria Dutaglandin comp. 0.5 mg/0.4 mg-Hartkapseln
Date of the Last Revision of this Leaflet:May 2023
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es